Dehydrocholic acid (triketo-5P-cholanoic acid) was synthesized from [24-14C] cholic acid, mixed with 200 mg of carrier, and administered intravenously to two patients with indwelling T tubes designed to permit bile sampling without interruption of the enterohepatic circulation. More than 80% of infused radioactivity was excreted rapidly in bile as glycine-and taurine-conjugated bile acids. Radioactive products were identified, after deconjugation, as partially or completely reduced derivatives of dehydrocholic acid. By mass spectrometry, as well as chromatography, the major metabolite (about 70%) was a dihydroxy monoketo bile acid (3a,7a-dihydroxy-12-keto-59-cholanoic acid); a second metabolite (about 20%) was a monohydroxy diketo acid (3a-hydroxy-7,12-diketo-5#-cholanoic acid); and about 10% of radioactivity was present as cholic acid. Reduction appeared to have been sequential (3 position, then 7 position, and then 12 position) and stereospecific (only a epimers were recovered).
INTRODUCTION 3,7,12-Triketo-5p-cholanoic acid,1 a triketo bile acid, is the major reaction product when cholic acid, a trihydroxy bile acid, is oxidized with chromic acid (2) . This compound (referred to in this paper as Tri-K-C) does not occur in bile under physiologic conditions but has been used for many years in man to stimulate bile flow (3) and to measure the circulation time (4) .
Secretion of phospholipids in bile appears to be induced by bile acid secretion (5) (6) (7) (8) (9) . Elucidation of the amphipathic properties of bile acids (10, 11) and the structure of the bile acid-lecithin micelle (12) provided a molecular explanation for the phospholipid-bile acid coupling observed during bile secretion and gave rise to the hypothesis, recently discussed in detail (8, 13) , that micelle formation was a prerequisite for phospholipid secretion. Since Tri-K-C does not form micelles at physiologic concentrations (14, 15) , it was 'Bile acids referred to in the text by trivial names or abbreviations have the following systematic names: dehydrocholic acid (Decholin) or triketocholanoic acid (Tri-K-C), 3,7,12-triketo-5,8-cholanoic acid; cholic acid, 3a,7a,12a-trihydroxy-5S-cholanoic acid; chenodeoxycholic acid, 3a,7a-dihydroxy-5,8-cholanoic acid; deoxycholic acid, 3a,12a-dihydroxy-5,-cholanoic acid; monohydroxy diketo metabolite (OH-di-K-C), 3a-hydroxy-7,12-diketo-5fi-cholanoic acid; dihydroxy monoketo metabolite (Di-OH-K-C), 3a,7a-dihydroxy-12-keto-5,8-cholanoic acid.
The Journal of Clinical Investigation Volume 52 March 1973 reasoned that experiments defining the effect of Tri-K-C on biliary phospholipid secretion might provide a test of the hypothesis. Indeed, evidence that Tri-K-C was less effective than cholic acid in stimulating phospholipid secretion was reported (13, 16) .
Another explanation for these observations was suggested by Hardison (16) who showed that, when Tri-K-C was given intravenously, it was excreted in bile Iargely as unidentified Tri-K-C metabolites which formed micelles poorly. Thus, both the decreased phospholipid coupling and the well-known hydrocholeretic effect of Tri-K-C (3, 17) could be related to properties of the metabolites rather than to those of Tri-K-C. The speculation that Tri-K-C was an osmotic choleretic (18, 19) because it did not form micelles could not be valid if Tri-K-C were not present in bile.
In this paper, we define the hepatic metabolism of Tri-K-C in man and characterize its effect on biliary lipid secretion. In addition, we performed limited studies on the ability of the Tri-K-C metabolites which we identified to disperse lecithin in micellar form in vitro.
METHODS
Radioactive bile acids [24-14C] (23) , the [14C]Tri-K-C was more than 98% radiopure. The free acid of Tri-K-C was converted to the sodium salt by titration with dilute sodium hydroxide, and the solution (pH 8-9) was diluted with sterile saline and passed through a membrane filter of 0.45 ,um pore size (Nalge Co., Rochester, N. Y.) for sterilization.
'Additional abbreviations used in this paper: GLC, gasliquid chromatography; PEG, polyethylene glycol; TLC, thin-layer chromatography.
Di-OH-K-C and OH-di-K-C. Methyl-'H esters of these compounds were prepared by using 'H-labeled methanol (New England Nuclear Corp.) saturated with boron trifluoride.
Reference compounds
Di-OH-K-C was prepared from cholic acid as described previously' (24), using procedures described by Fieser and Rajagopalan (25) and Sato and Ikekawa (20) . The product was recrystallized from ethyl acetate by the addition of ligroine (petroleum ether).
OH-di-K-C was synthesized by chromic acid oxidation of methyl 3a-carbethoxy-7a,12a-dihydroxy-5f-cholanoate (25) followed by saponification, methylation, and chromatography on silica gel with a gradient of acetone-benzene used for elution. Pure fractions were pooled, and the compound was recrystallized from 95% ethanol by the addition of water. Both compounds were pure by TLC and GLC. (21) . The location of radioactivity was determined by using a zonal scanning device (22) , which transfers 4-mm bands of the adsorbent to counting vials; ethanol and a toluene-based scintillation cocktail were added and radioactivity was determined by liquid scintillation spectroscopy.
GLC of the methyl esters of the free bile acids was carried out at 250'C on 4-ft columns packed with 3% QF-1 (methyl fluoroalkyl silicone) on Gas-Chrom S; helium was the carrier gas and a hydrogen flame detector was used. Bile acids were also esterified with methanol and acetylated (27) . Reference Solubility studies A series of mixtures of the sodium salts of cholic acid, OH-di-K-C, and Di-OH-K-C with highly purified egg lecithin (Pierce Chemical Co., Rockford, Ill.) was prepared. Bile acid concentrations were 0-30 mM; lecithin concentrations were varied reciprocally so that the total concentration of bile acids and lecithin was 30 mM. In the triangular phase diagram of the ternary system of bile acid-lecithinwater, the series of mixtures falls on a line parallel to the base opposite the water corner; this experimental design has been described elsewhere in more detail (30) . To each vial 1 ml of sterile N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer (A grade, Calbiochem, Los Angeles, Calif.) was added and the volume was adjusted to 5 ml with sterile isotonic saline. After equilibration with nitrogen, each vial was flame sealed. Vials were shaken vigorously for at least 24 h on a Dubnoff metabolic shaker (Precision Scientific Co., Chicago, Ill.). Turbidity was estimated visually. The vials were then opened and the contents were centrifuged at 2,000 rpm for 30 min. The supernate, which was free from large particles of lecithin, was then centrifuged in a type 50 or 5OTi rotor in a Beckman L2-65B ultracentrifuge (Beckman Instruments, Inc., Fullerton, Calif.) at 100,000 g (50,000 rpm) for 2 h at 250C. The clear supernate, containing the micellar phase, was then removed from the cellulose nitrate tubes by puncturing the side of the tube with a syringe and needle. The concentration of phospholipids in the micellar phase was measured by the Fiske and Subbarow method (31) .
Physiologic studies
Metabolism after intravenous administration. After their informed consent was obtained, two women were studied 2 wk after cholecystectomy and common duct exploration for cholesterol gallstones. A balloon-occludable reinfusion T tube (32) was inserted. The enterohepatic circulation was restored for at least 48 h before the study by clamping the drainage limb of the T tube. After the balloon was inflated to achieve occlusion, a complete collection of hepatic bile was obtained. The enterohepatic circulation was maintained by reinfusion of bile-salt-enriched bile (previously obtained from other bile fistula patients) through another lumen of the T tube, which bypassed the balloon and emptied into the distal common bile duct.
On the day of the study, a solution containing 200 mg and 20 ,uCi of the sodium salt was infused intravenously for 15 min. (This is equivalent to the amount of Tri-K-C used in the test for circulation time; however, the rate of delivery was much slower in this study.) Bile flow was measured in graduated cylinders to the nearest 0.1 ml in 30-min collection intervals for 10 h. Lipids in bile were measured as previously described (33) . A 24 h collection of urine was obtained from patient 2.
Metabolism after duodenal administration. A cholecystectomized woman was intubated with a double-lumen polyvinyl tube. The perfusion lumen was positioned in the second portion of the duodenum and the collection lumen was located 40 cm distally. Saline containing polyethylene glycol (PEG, mol wt 4000), 5 g/liter, was infused for 100 mim to establish a base line. Then, the same solution containing "C-labeled Tri-K-C (220 mg; 6 uCi) was infused for 10 min. After this, perfusion was continued for 4 h with the PEG saline solution, but an essential amino acid mixture, known to evoke cholecystokinin-pancreozymin release, was added to simulate the postprandial condition and ensure a good bile flow (34) . Absorption of Tri-K-C in the 40 cm test segment and biliary secretion of Tri-K-C metabolites were calculated from the concentration changes relative to the PEG.
RESULTS

Metabolism of Tri-K-C after intravenous administration
Time-course and route of excretion. 82 and 86% of the administered dose was recovered in bile during the 10 h after administration in the two patients; 91 and 96% of the total biliary radioactivity recovered was secreted within 2 h after the dose (Fig. 1) . 10% of the administered dose was present in a 24 h collection of urine in the one patient (patient 2) examined.
Chemical form of radioactivity in whole bile. All radioactivity present in bile during peak excretion had the TLC mobility of conjugated bile acids, 79 and 89% as glycine-conjugated and 21 and 11% as taurineconjugated bile acids, respectively, in the two patients (Table I) . After incubation of whole bile with cholyl amidase (bile acid deconjugase) activity (26), the Time, hours FIGURE 1 Cumulative excretion of "C radioactivity into bile after intravenous administration of "4C-labeled Tri-K-C. 82 and 86% of the administered dose was recovered in bile during the 10 h after administration. The half-time for the period of rapid excretion is about i h in each patient; for the period of slow excretion, it is 11.5 h in patient 1 and 5 h in patient 2. (Fig. 2) .
Radio-GLC. Two peaks were clearly separated from the usual biliary bile acids and had retention times corresponding to synthetic standards (as acetates) of 3a-hydroxy-7,12-diketo-5p-cholanoic acid (the monohydroxy diketo metabolite, OH-di-K-C) and 3a,7a-dihydroxy-12-keto-5p-cholanoic acid (the dihydroxy monoketo metabolite, Di-OH-K-C) (Fig. 3) . The majority of the radioactivity was present in the first two metabolites, with a small amount in cholic acid. No radioactivity was present in fractions with retention times corresponding to those of Tri-K-C and chenodeoxycholic and deoxycholic acids.
Co-chromatography. Synthetic Di-OH-K-C and OHdi-K-C were esterified with [3H]methanol and mixed with the biliary bile acid methyl esters (which contained "C in the carboxyl group). Chromatographic mobilities of the two isotopes were identical on adsorption (TLC) and partition (GLC) chromatography, providing further evidence for the chemical identity of the metabolites.
Mass spectrometry. Mass spectra of the methyl ester acetates (Fig. 4) of the two metabolites isolated from the biliary bile acids were identical to those of synthetic OH-di-K-C and Di-OH-K-C, establishing their Chemical form of radioactivity. Radioactivity present as conjugated bile acids appeared promptly in aspirates (within 10 min). The rate of secretion of radioactivity was highest during the 1st h, but secretion was maintained throughout the entire 3 h study. Conjugated bile acid radioactivity had the mobility of glycine conjugates or taurine conjugates and, after hydrolysis, was present predominantly as cholic acid and hydroxy keto bile acids identical to those previously identified in bile after intravenous administration of Tri-K-C (Table I ). The ratio of hydroxy keto metabolites to cholic acid was similar to that observed in bile after intravenous administration of Tri-K-C. Since the total radioactivity recovered in conjugated bile acids was about 96% of that in the Tri-K-C available for absorption (infused minus aspirated), we have no proof that Tri-K-C metabolites circulated enterohepatically during the 3 h of our experiment. Only 2% of infused radioactivity was excreted in urine during the 24 h after infusion.
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Hydrocholeretic effect of Tr-K-C Bile flow correlated positively with bile acid output (r = 0.56, patient 1; r = 0.71, patient 2). However, bile flow was strikingly greater (P < 0.01) for samples containing Tri-K-C metabolites during periods when total bile acid concentrations were similar (Table II) .
Failure of Tri-K-C to decrease biliary lipid secretion
The ratio of the bile acids plus phospholipids to cholesterol (lipid ratio) for each 30 min collection period was measured before, during, and after intravenous Tri-K-C infusion. In patient 1, the lipid ratio increased even when Tri-K-C metabolites represented 21% of biliary bile acids. In patient 2, the lipid ratio remained unchanged despite Tri-K-C metabolites increasing to 32% of the biliary bile acids (Fig. 6) . Outputs of phospholipids and cholesterol were maintained or increased during these periods.
In vitro solubilization of lecithin by Tri-K-C metabolites
The monohydroxy diketo metabolite, OH-di-K-C, possessed little ability to solubilize lecithin. Although the dihydroxy monoketo metabolite, Di-OH-K-C, had somewhat greater solubilizing properties, it was strikingly inferior to cholate. With Tri-K-C metabolites, turbidity, indicating that lecithin was present in excess of its micellar solubility, was present at a lecithin-bile acid Time, hours FIGURE 6 Ratio of bile acids (BA) plus phospholipids (PL) to cholesterol (Ch) before, during, and after intravenous Tri-K-C administration (30-min periods). The arrows pointing upward indicate the ingestion of breakfast and lunch. ratio of 1:9 whereas with cholate, turbidity did not occur until a ratio of 1: 1.5 (Fig. 7) .
In a second group of experiments, cholate was replaced stoichiometrically and stepwise by OH-di-K-C or Di-OH-K-C, and the ability of the resultant mixtures to disperse 6 mM lecithin was assessed (Fig. 8) . Mixtures of Di-OH-K-C and cholate were as effective as cholate alone until more than 60% of the cholate had been replaced by the dihydroxy monoketo derivative; after that, the solubilizing properties of the bile acid mixtures decreased markedly. Mixtures with OH-di-K-C were equivalent to cholate until more than 40% of the cholate had been replaced by the Tri-K-C metabolite. Replacement ability was inversely proportional to the number of keto groups in the Tri-K-C metabolite. DISCUSSION Biotransformations. The nearly complete recovery of radioactivity in only three metabolites, all possessing one or more a-hydroxy constituents, suggests that Tri-K-C was sequentially and stereospecifically reduced. It seems likely, based on animal models (16) , that the liver was the site of the observed biotransformations. It is possible that the pattern of metabolites observed in our studies is dose-related, and our findings are not necessarily in coiflict with those of Ellin, Mendeloff, and Turner (36) who detected Tri-K-C in bile, apparently in unconjugated form, after 1 g of Tri-K-C was given intravenously. Since the intestinal absorption and hepatic metabolism of the two metabolites has not been characterized and since no information is available on bacterial metabolism of the metabolites or on the intestinal absorption and hepatic metabolism of the products resulting from bacterial biotransformations, our data cannot be used to predict the effect of continuous ingestion of Tri-K-C on biliary bile acid composition. At high lecithin-bile acid ratios, excess lecithin is present in liquid crystalline aggregates (11) containing an unknown amount of bile acid.
Our data are in general agreement with qualitative observations on the hepatic metabolism of Tri-K-C in rats (16) , rabbits (37, 38) , guinea pigs (39) , and dogs (40) . Bile acids possessing a keto group at the 3 position have been shown to be reduced by rat liver in vitro and in vivo (4145). There is limited evidence suggesting that the 7-keto group of bile acids is reduced during hepatic passage (46) , and recently evidence for hepatic reduction of the 12-keto group of Di-OH-K-C has been reported (47) . The enzyme system mediating a reduction of the 3-keto group of bile acids in man has not been characterized, although information on a steroid 3-hydroxy dehydrogenase present in rat liver has been published (45) ; the enzyme described in these studies may or may not be the same enzyme involved in reduction of the 3-keto group of bile acids. To our knowledge, there has been no attempt to characterize the enzyme which reduces the 7-keto group, but a 12-keto reduction has been shown to be present in rat liver microsomes (47) . In our experiments, reduction appeared to be sequential. Reduction at the 3 position occurred first and the rate was significantly greater than at the 7 position where it occurred second and in turn was greater than at the 12 position (ratio of rates at 3, 7, and 12 positions = 17: 10:1); no quantitative interpretation of these data is possible.
The duodenal infusion experiment indicates that Tri-K-C is absorbed from the proximal small intestine, and that small intestinal absorption of Tri-K-C, before hepatic passage, does not substantially alter the pattern of metabolites appearing in bile. The most reasonable explanation of this finding is that Tri-K-C was not reduced during passage through the mucosal cell, although intestinal reduction similar to that occurring in the liver cannot be excluded.
Tri-K-C conjugated with glycine is not metabolized during passage through the rabbit liver (48) . Thus, in this species, conjugation appears to render the keto groups of certain bile acids inaccessible to hepatic reductases.
The biologic significance of reduction of keto groups on bile acids is unclear. In man, keto bile acids have been identified in stool (49) but are rare in bile (50, 51) . Although it has been assumed that absorption of keto bile acids from the colon is negligible, perhaps the magnitude of such absorption may be greater than previously suspected. Parenthetically, it should be noted that 7-keto acids compose a significant fraction of bile in a number of mammals (52) .
Tri-K-C choleresis. Our work confirms a large body of experimental evidence in animals and limited evidence in man that Tri-K-C or its metabolites increase bile flow more than the usual biliary bile acids-that is, cause a hydrocholeresis. This hydrocholeretic effect cannot be explained by osmosis, even if the metabolites were not participating in micelle formation, because the increased flow occurred at a time when the Tri-K-C metabolites accounted for a small proportion of the bile salts in bile. Forker (53) showed that Tri-K-C infusion increased biliary clearance of mannitol and erythritol in the guinea pig but that secretin did not; his data suggest that Tri-K-C increases canalicular bile production. By definition, the hydrocholeresis induced by the Tri-K-C metabolites represents the "bile salt dependent fraction" of bile flow but it seems more reasonable to assign the increment in water flow to a "secretory" fraction as distinguished from an "osmotic" fraction. Bargeton, Salesse, Barber, and Delavierre (54) made a systematic comparison of the choleretic potency of a number of tri-substituted hydroxy keto bile acids given intravenously to anesthetized rabbits. Their results are difficult to interpret since hepatic metabolism was not defined, but they did show that Di-OH-K-C had a choleretic potency identical to that of Tri-K-C, and that OH-di-K-C was twice as potent. These experiments indicate that hydrocholeresis can be induced by metabolites and that the presence of an intact Tri-K-C molecule is not essential.
Our experiments shed no light on the mechanism of hydrocholeresis induced by Tri-K-C. Recent work has shown that dihydroxy bile acids, but not trihydroxy bile acids, induce water secretion by the human colon (55) and jejunum (56) , and the action of Tri-K-C metabolites on bile flow could be related to this poorly understood secretory property of bile acids. The dihydroxy bile acids activate the Na'-activated ATPase of intestinal mucosa, but OH-di-K-C is the most potent activator of this brush border enzyme observed to date (57) . If OH-di-K-C is shown to have a potent secretory effect in a variety of tissues, detailed studies of the pharmacology of this compound would appear indicated.
Tri-K-C excretion and bile acid-phospholipid coupling. The seeming discrepancy between our results, which indicate no change in bile salt-phospholipid coupling after Tri-K-C administration, and those of Hardison (16) , Wheeler and King (8) , and Young and Hanson (48) , which indicate that Tri-K-C infusions decrease phospholipid and cholesterol output, was clarified by the in vitro solubility studies which showed that the ratio of Tri-K-C metabolites to cholate determines the degree of lecithin solubilization. In those studies, Tri-K-C metabolites composed the majority of bile acids in bile, precluding efficient micellar solubilization of lecithin. In our study, the enterohepatic circulation was intact, with the result that the amount of Tri-K-C infused was small relative to that of circulating bile acids. Lipid output was not depressed because the metabolites acted cooperatively with endogenous di-and trihydroxy bile acids to solubilize lecithin.
Structure-function relationships. These studies point out the striking effects caused by alteration in the ring substituents of bile acids and complement previous studies indicating the importance of the steric configuration of the A/B ring juncture (58) (59) (60) . The special properties of Tri-K-C and its metabolites appear to be caused by the presence of a keto group rather than the absence of a hydroxyl group.
